[Federal Register Volume 63, Number 67 (Wednesday, April 8, 1998)]
[Notices]
[Page 17196]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-9241]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
National Institute of Allergy and Infectious Diseases Special Emphasis
Panel (SEP) meetings:
Name of SEP: Adoptive transfer of CD8+CTL's to Control EIAV.
Date: April 20, 1998.
Time: 2:00 p.m. to Adjournment.
Place: Teleconference, Solar Building, Room 4C12, 6003 Executive
Blvd., Bethesda, MD 20892, (301) 496-2550.
Contact Person: Dr. Kevin Ryan, Scientific Review Adm., 6003
Executive Boulevard, Solar Bldg., Room 4C12, Bethesda, MD 20892,
(301) 496-2550.
Purpose/Agenda: To evaluate a grant application.
Name of SEP: In Vitro Antiviral Screens.
Date: April 23-24, 1998.
Time: 8:00 a.m. to Adjournment.
Place: Chevy Chase Holiday Inn, Terrace Room, 5520 Wisconsin
Avenue, Chevy Chase, MD 20815, (301) 654-1000.
Contact Person: Dr. Peter R. Jackson, Scientific Review Adm.,
6003 Executive Boulevard, Solar Bldg., Room 4C10, Bethesda, MD
20892, (301) 496-2550.
Purpose/Agenda: To evaluate contract proposals.
These meetings will be closed in accordance with the provisions
set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C.
Applications and/or proposals and the discussions could reveal
confidential trade secrets or commercial property such as patentable
material and personal information concerning individuals associated
with the applications and/or proposals, the disclosure of which
would constitute a clearly unwarranted invasion of personal privacy.
(Catalog of Federal Domestic Assistance Programs Nos. 93.855,
Immunology, Allergic and Immunologic Diseases Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health)
Dated April 2, 1998,
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-9241 Filed 4-7-98; 8:45 am]
BILLING CODE 4140-01-M
